IBDEI1E3 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24920,1,4,0)
 ;;=4^302.71
 ;;^UTILITY(U,$J,358.3,24920,1,5,0)
 ;;=5^Loss Of Libido
 ;;^UTILITY(U,$J,358.3,24920,2)
 ;;=^1
 ;;^UTILITY(U,$J,358.3,24921,0)
 ;;=596.54^^145^1533^38
 ;;^UTILITY(U,$J,358.3,24921,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24921,1,4,0)
 ;;=4^596.54
 ;;^UTILITY(U,$J,358.3,24921,1,5,0)
 ;;=5^Neurogenic Bladder 
 ;;^UTILITY(U,$J,358.3,24921,2)
 ;;=^304798
 ;;^UTILITY(U,$J,358.3,24922,0)
 ;;=788.43^^145^1533^39
 ;;^UTILITY(U,$J,358.3,24922,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24922,1,4,0)
 ;;=4^788.43
 ;;^UTILITY(U,$J,358.3,24922,1,5,0)
 ;;=5^Nocturia
 ;;^UTILITY(U,$J,358.3,24922,2)
 ;;=^84740
 ;;^UTILITY(U,$J,358.3,24923,0)
 ;;=605.^^145^1533^42
 ;;^UTILITY(U,$J,358.3,24923,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24923,1,4,0)
 ;;=4^605.
 ;;^UTILITY(U,$J,358.3,24923,1,5,0)
 ;;=5^Phimosis
 ;;^UTILITY(U,$J,358.3,24923,2)
 ;;=^104159
 ;;^UTILITY(U,$J,358.3,24924,0)
 ;;=601.0^^145^1533^44
 ;;^UTILITY(U,$J,358.3,24924,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24924,1,4,0)
 ;;=4^601.0
 ;;^UTILITY(U,$J,358.3,24924,1,5,0)
 ;;=5^Prostatitis, Acute
 ;;^UTILITY(U,$J,358.3,24924,2)
 ;;=^259106
 ;;^UTILITY(U,$J,358.3,24925,0)
 ;;=590.10^^145^1533^46
 ;;^UTILITY(U,$J,358.3,24925,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24925,1,4,0)
 ;;=4^590.10
 ;;^UTILITY(U,$J,358.3,24925,1,5,0)
 ;;=5^Pyelonephritis, Acute
 ;;^UTILITY(U,$J,358.3,24925,2)
 ;;=^270369
 ;;^UTILITY(U,$J,358.3,24926,0)
 ;;=590.00^^145^1533^47
 ;;^UTILITY(U,$J,358.3,24926,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24926,1,4,0)
 ;;=4^590.00
 ;;^UTILITY(U,$J,358.3,24926,1,5,0)
 ;;=5^Pyelonephritis, Chronic
 ;;^UTILITY(U,$J,358.3,24926,2)
 ;;=^270367
 ;;^UTILITY(U,$J,358.3,24927,0)
 ;;=788.7^^145^1533^54
 ;;^UTILITY(U,$J,358.3,24927,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24927,1,4,0)
 ;;=4^788.7
 ;;^UTILITY(U,$J,358.3,24927,1,5,0)
 ;;=5^Urethral Discharge
 ;;^UTILITY(U,$J,358.3,24927,2)
 ;;=^265872
 ;;^UTILITY(U,$J,358.3,24928,0)
 ;;=131.02^^145^1533^57
 ;;^UTILITY(U,$J,358.3,24928,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24928,1,4,0)
 ;;=4^131.02
 ;;^UTILITY(U,$J,358.3,24928,1,5,0)
 ;;=5^Urethritis, Trichomonal
 ;;^UTILITY(U,$J,358.3,24928,2)
 ;;=^266955
 ;;^UTILITY(U,$J,358.3,24929,0)
 ;;=597.80^^145^1533^55
 ;;^UTILITY(U,$J,358.3,24929,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24929,1,4,0)
 ;;=4^597.80
 ;;^UTILITY(U,$J,358.3,24929,1,5,0)
 ;;=5^Urethritis NOS
 ;;^UTILITY(U,$J,358.3,24929,2)
 ;;=Urethritis, NOS^124214
 ;;^UTILITY(U,$J,358.3,24930,0)
 ;;=788.41^^145^1533^58
 ;;^UTILITY(U,$J,358.3,24930,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24930,1,4,0)
 ;;=4^788.41
 ;;^UTILITY(U,$J,358.3,24930,1,5,0)
 ;;=5^Urinary Frequency
 ;;^UTILITY(U,$J,358.3,24930,2)
 ;;=^124396
 ;;^UTILITY(U,$J,358.3,24931,0)
 ;;=788.31^^145^1533^62
 ;;^UTILITY(U,$J,358.3,24931,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24931,1,4,0)
 ;;=4^788.31
 ;;^UTILITY(U,$J,358.3,24931,1,5,0)
 ;;=5^Urinary Incontinence,Urge
 ;;^UTILITY(U,$J,358.3,24931,2)
 ;;=^260046
 ;;^UTILITY(U,$J,358.3,24932,0)
 ;;=788.20^^145^1533^63
 ;;^UTILITY(U,$J,358.3,24932,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24932,1,4,0)
 ;;=4^788.20
 ;;^UTILITY(U,$J,358.3,24932,1,5,0)
 ;;=5^Urinary Retention
 ;;^UTILITY(U,$J,358.3,24932,2)
 ;;=^295812
 ;;^UTILITY(U,$J,358.3,24933,0)
 ;;=112.2^^145^1533^66
 ;;^UTILITY(U,$J,358.3,24933,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,24933,1,4,0)
 ;;=4^112.2
 ;;^UTILITY(U,$J,358.3,24933,1,5,0)
 ;;=5^Urogenital Candidiasis
 ;;^UTILITY(U,$J,358.3,24933,2)
 ;;=^266866
 ;;^UTILITY(U,$J,358.3,24934,0)
 ;;=600.01^^145^1533^5
